Companies / Information Technology
KEYS
Keysight Technologies
Electronic Equipment & Instruments
Electronic Equipment & InstrumentsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health75
Growth38
Profitability65
Cash generation98
Balance sheet92
Dilution control80
Key ratios and five-year financials
Latest quarter revenue YoY (2026-07-31)36.5%Revenue growth (FY)8.0%Revenue CAGR (3y)-0.3%Gross margin62.1%Operating margin16.3%Net margin15.8%Free cash flow margin23.8%R&D / revenue18.7%Stock comp / revenue3.0%Net debt / operating cash flow0.47xCurrent ratio2.35Diluted share count change-1.1%
| Fiscal year ending | FY 2021-10 | FY 2022-10 | FY 2023-10 | FY 2024-10 | FY 2025-10 |
|---|---|---|---|---|---|
| Revenue | $4.9B | $5.4B | $5.5B | $5.0B | $5.4B |
| Gross profit | $3.1B | $3.5B | $3.5B | $3.1B | $3.3B |
| Operating income | $1.1B | $1.3B | $1.4B | $833M | $876M |
| Net income | $894M | $1.1B | $1.1B | $614M | $850M |
| Operating cash flow | $1.3B | $1.1B | $1.4B | $1.1B | $1.4B |
| Capital expenditure | $174M | $185M | $197M | $154M | $128M |
| Free cash flow | $1.1B | $959M | $1.2B | $898M | $1.3B |
| R&D | $811M | $841M | $882M | $919M | $1.0B |
| Stock-based comp | $103M | $125M | $135M | $137M | $162M |
| Buybacks | $673M | $849M | $702M | $439M | $375M |
| Cash | $2.1B | $2.0B | $2.5B | $1.8B | $1.9B |
| Total debt | $1.8B | $1.8B | $2.4B | $1.8B | $2.5B |
| Equity | $3.8B | $4.2B | $4.7B | $5.1B | $5.9B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.